| James Donald Vinson Jr, MD | |
|
1388b Wellbrook Cir Ne, Conyers, GA 30012-3872 | |
| (770) 388-7745 | |
| (770) 922-0526 |
| Full Name | James Donald Vinson Jr |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 36 Years |
| Location | 1388b Wellbrook Cir Ne, Conyers, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235100082 | NPI | - | NPPES |
| 000495723A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 035348 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Indiana Anesthesia Associates, Llc | 6709234750 | 15 |
News Archive
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.
› Verified 2 days ago
| Entity Name | Anesthesia Care Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073899449 PECOS PAC ID: 6608042288 Enrollment ID: O20120103000455 |
News Archive
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.
› Verified 2 days ago
| Entity Name | Anesthesia Dynamics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073001012 PECOS PAC ID: 3779832530 Enrollment ID: O20191011000052 |
News Archive
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.
› Verified 2 days ago
| Entity Name | Northern Indiana Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033891510 PECOS PAC ID: 6709234750 Enrollment ID: O20231130003347 |
News Archive
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Donald Vinson Jr, MD 1388b Wellbrook Cir Ne, Conyers, GA 30012-3872 Ph: (770) 388-7745 | James Donald Vinson Jr, MD 1388b Wellbrook Cir Ne, Conyers, GA 30012-3872 Ph: (770) 388-7745 |
News Archive
A new study examining the aftereffects of a chlorine gas disaster in a South Carolina town gives larger metropolitan areas important insight into what to expect and how to prepare emergency response systems for an accidental or terrorist release of the potentially deadly gas.
Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.
Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.
The goal of any cancer treatment is to kill tumor cells. Yet, one little understood paradox of certain cancers is that the body's natural process for removing dead and dying cells can actually fuel tumor growth.
On October 9, 2015, the board of directors of the Chemical Heritage Foundation (CHF) in Philadelphia approved a merger with the Life Sciences Foundation (LSF) of San Francisco. On October 11, the Life Sciences Foundation board approved the same plan.
› Verified 2 days ago
Efosa Omonuwa Ogiamien, MD Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 1388 Wellbrook Cir Ne Ste A, Conyers, GA 30012 Phone: 404-920-4950 Fax: 404-920-4959 | |
Selwynn Brian Howard, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1359 Milstead Rd Ne, Suite 103, Conyers, GA 30012 Phone: 770-388-7745 Fax: 770-922-0526 | |
Hung Pham, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1388b Wellbrook Cir Ne, Conyers, GA 30012 Phone: 770-388-7745 Fax: 770-922-0526 | |
Dinah Franklin, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1359 Milstead Rd Ne, Suite 103, Conyers, GA 30012 Phone: 770-388-7745 Fax: 770-922-0526 | |
Dr. Roy Lamar Talley Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1301 Sigman Rd Ne, Suite 100, Conyers, GA 30012 Phone: 770-760-9360 Fax: 770-760-9303 | |
Sadik N Haba, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1301 Sigman Rd Ne, Ste 100, Conyers, GA 30012 Phone: 770-760-9360 |